Suppression of TNT formation by targeting the mTOR pathway either directly with everolimus, or indirectly with metformin, demonstrated that TNT suppression negatively regulates intercellular transfer, marking mTOR and related downstream players as potential targets for disrupting TNT function in ovarian carcinomas (8) and mesotheliomas (47). This evidence concerns the gene MTOR and mesothelioma.